Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 24. Juni 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8960  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 179188  
   
Papillary Renal Neoplasm with Reversed Polarity in a 64-Year-Old Male: A Rare Case Report and Review of the Literature.
Int Med Case Rep J
Wang Y, Zhang M, Su G, Zhou Q.
PMID: 42339132 [PubMed - in process]


Exploring the molecular link between arecoline exposure and prostate cancer-related alterations: integrative evidence from network toxicology, single-cell transcriptomics, molecular simulation, and experimental validation.
Front Pharmacol
Zhu X, Liu H, Zeng Z, Zou L, Zhou Y, Zhou T.
PMID: 42338969 [PubMed - in process]


Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation.
Front Immunol
Su T, Jiang F, Gao J, Li X, Cheng H, Wang Y.
PMID: 42338588 [PubMed - in process]


The feasibility of [(18)F]PSMA-1007 PET/CT for response assessment in prostate cancer following neoadjuvant androgen deprivation therapy compared with mpMRI.
Cancer Imaging
Cho S, Seo HJ, Han H, Lee S, Jeon TJ, Oh YT, Jung M, Yun M.
PMID: 42337687 [PubMed - as supplied by publisher]


Identification of alpha1-oleate as a potent regulator of adipokine-dependent metabolism, in bladder cancer tissue.
Cancer Metab
Haq F, Chinchankar S, Ambite I, Ahmadi S, Tran H, Nazari A, Brisuda A, Hacek J, Babjuk M, Svanborg C.
PMID: 42337683 [PubMed - in process]


Multi-omics integration and clinical validation identify CKAP2 as a diagnostic biomarker for bladder cancer.
World J Surg Oncol
Li X, Yang J, Cha J, Xie H, Dong C, Yang Y, Li Y, Guo J, Lin C.
PMID: 42337544 [PubMed - as supplied by publisher]


Multifactorial diagnostic model combining SAT-PCA3 in prostate cancer.
Discov Oncol
Luo Z, Dai S, Jin J, Xie W, Lei S, He Y.
PMID: 42337216 [PubMed - as supplied by publisher]


Front-line chemo-immunotherapy for advanced penile cancer: ready for prime time?
Br J Cancer
Thomas Z, Pettaway CA, Alhalabi O, Campbell MT, Johns AC.
PMID: 42337045 [PubMed - as supplied by publisher]


How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management?
Eur Urol Focus
Beauregard JM, Ong M, Pouliot F.
PMID: 42336749 [PubMed - as supplied by publisher]


Re: Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men with Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE).
Eur Urol
Ma H, Zhang L.
PMID: 42336727 [PubMed - as supplied by publisher]


MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.
J Clin Pathol
Saeed F, Osunkoya AO.
PMID: 42336636 [PubMed - as supplied by publisher]


A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the Bladder.
Urology
Roberson DS, Wang MK, McLeay Ii MT, Wei N, Potretzke T, Gupta S, Cheville JC, Kern R, Lomas D, Mynderse L, Khanna A, Shah P, Tollefson MK, Jeffrey Karnes R, Boorjian SA, Sharma V.
PMID: 42336158 [PubMed - as supplied by publisher]


Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.
Cell Rep Med
Grande E, Sibai M, Grases D, Andrada E, Reig O, Escobosa M, Azueta A, Castellano D, Puente J, Martínez de Villarreal J, Font A, Alonso-Gordoa T, Benítez R, Moreno-Oya A, Álvarez-Maestro M, Burgos J, Climent MA, Domínguez M, Galván P, Galante I, García JF, Perez E, García Del Muro X, Guerrero-Ramos F, Marqués M, Maroto P, Paramio JM, Pinto A, Prat A, Malats N, Durán I, Porta-Pardo E, Real FX.
PMID: 42335902 [PubMed - as supplied by publisher]


A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies.
JCO Clin Cancer Inform
Roy P, Schut I, Graf N, Verschuur A, Chowdhury T, Spreafico F, Brok J, Ramirez-Villar GL, de Camargo B, Godzinski J, Vujanic G, Melchior P, Koolma R, Al-Saadi R, Gessler M, Duncan C, Schenk JP, Furtwängler R, Bonnange HS, Metzger S, Baars D, Pritchard-Jones K, van den Heuvel-Eibrink MM, van Tinteren H.
PMID: 42335412 [PubMed - indexed for MEDLINE]


Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity.
Prostate
Quarta L, Petix M, Filzmayer M, Orlandi F, Polverino F, Goyal JA, Ferro M, Chun FKH, Micali S, Longo N, Shariat SF, Barletta F, Stabile A, Gandaglia G, Montorsi F, Saad F, Briganti A, Karakiewicz PI.
PMID: 42335306 [PubMed - as supplied by publisher]


Contrast-Enhanced Ultrasound as a Next-Step Tool After Indeterminate CT in ESRD.
Ultrasound Q
Mc Caughey M, Gustainis D, Ambrosio M, Sambommatsu Y, Imai D, Sharma A, Khan A, Lee SD, Bruno D, Prasad U, Saeed M.
PMID: 42335288 [PubMed - indexed for MEDLINE]


Correlation of Prostate Tumor Laterality with Pelvic Lymph Node Metastasis Patterns- A Retrospective Observational Study.
Urol Int
Masoumi N, Alinejad Khorram A, Beheshti M, Rabani S, Torabi A, Razi A, Jafarlou D.
PMID: 42334984 [PubMed - as supplied by publisher]


Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.
Minerva Urol Nephrol
Rescigno P, Taha T, Fita MJ, Matthews D, Fujita K, Lolli C, DI Costanzo F, Juárez A, Ürün Y, Yazgan SC, Li H, Facchini G, Quiroga MN, Sammarco E, Bögemann M, Santini D, Baranseh J, Roviello G, Kopp RM, Fiala O, Büttner T, Carrozza F, Ansari J, Tural D, Conteduca V, Molina-Cerrillo J, Alonso-Gordoa T, Bourlon MT, Palacios GA, Paolieri F, Zgura A, DI Rocco R, Lacerenza LG, Matrana MR, Martignetti A, Massari F, Soares A, Monteiro FS, Bastos DA, Gaughan L, Wenzel M, Mandel P, Banna GL, Santoni M.
PMID: 42334408 [PubMed - as supplied by publisher]


Clinically Significant Prostate Cancer in Patients Undergoing Holmium Laser Enucleation of Prostate for Benign Hyperplasia: A Preoperative Nomogram and a Postoperative Surveillance Protocol.
J Endourol
Singh G, Bakbak H, Abdelaziz A, Resnik S, Ospina JV, Katz JE, Marcovich R, Khandekar A, Punnen S, Gonzalgo ML, Parekh DJ, Shah HN.
PMID: 42333981 [PubMed - as supplied by publisher]


UBE2C contributes to malignant phenotypes in clear cell renal cell carcinoma via cell cycle and apoptosis regulation.
PeerJ
Qin T, Liang J, Ya W, Long Y, Wu J, Meng D, Gan F.
PMID: 42333228 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 179188    Seite 1 von 8960  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1